HomeGERN • NASDAQ
add
Geron Corp
Previous close
$4.32
Day range
$4.22 - $4.35
Year range
$1.64 - $5.34
Market cap
2.57B USD
Avg Volume
8.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 882.00K | 2,941.38% |
Operating expense | 39.42M | 139.05% |
Net income | -67.38M | -36.88% |
Net profit margin | -7.64K | 95.50% |
Earnings per share | -0.10 | -11.11% |
EBITDA | -69.07M | -33.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 362.73M | -2.33% |
Total assets | 449.40M | 8.21% |
Total liabilities | 142.70M | 22.11% |
Total equity | 306.70M | — |
Shares outstanding | 602.80M | — |
Price to book | 8.47 | — |
Return on assets | -37.22% | — |
Return on capital | -42.01% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -67.38M | -36.88% |
Cash from operations | -53.48M | -80.66% |
Cash from investing | -36.15M | 18.67% |
Cash from financing | 16.83M | -8.22% |
Net change in cash | -72.81M | -30.71% |
Free cash flow | -29.00M | -160.87% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
141